VOLITIONRX LTD — Director's Dealing 2021

Sep 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2021-09-21-05:00

Reporting Person: Faulkes Martin Charles (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-16-05:00	Option (Right to Buy)	$5.00	D	66533	Disposed	2023-03-30-05:00	Common Stock (66533)	Direct
2021-09-21-05:00	Option (Right to Buy)	$5.00	A	66533	Acquired	2027-03-30-05:00	Common Stock (66533)	Direct
2020-04-13-05:00	Option (Right to Buy)	$3.60	D	70000	Disposed	2026-04-13-05:00	Common Stock (70000)	Direct
2021-09-21-05:00	Option (Right to Buy)	$3.60	A	70000	Acquired	2030-04-13-05:00	Common Stock (70000)	Direct

Footnotes

F1: The reported transactions involved a cancellation and reissuance of outstanding options upon agreement of the reporting person. The "old" options were originally granted on December 16, 2019, vested in full on the date of grant, and were exercisable until March 30, 2023. The "replacement" options are fully-vested on the date of grant and have an expiration date of March 30, 2027.

F2: The reported transactions involved a cancellation and reissuance of outstanding options upon agreement of the reporting person. The "old" options were originally granted on April 13, 2020 and vested in full at 12 months from the date of grant, and were exercisable until April 13, 2026. The "replacement" options are fully-vested on the date of grant and have an expiration date of April 13, 2030.